Reactivation of Human Herpesviruses after Allogeneic Peripheral Blood Stem Cell Transplantation and Bone Marrow Transplantation

References

• Singhal S., Mehta J. Reimmunization after blood or marrow stem cell transplantation [see comments]. Bone Marrow Transplant 1999; 23: 637–46
   PubMed Web of Science ®Google Scholar
• Guillaume T., Rubinstein D. B., Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471–90
   PubMed Web of Science ®Google Scholar
• Ljungman P., Lewensohn-Fuchs I., Hammarstrom V., Aschan J., Brandt L., Bolme P., Lonnqvist B., Johansson N., Ringden O., Gahrton G. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657–63
   PubMed Web of Science ®Google Scholar
• Lum L. G. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369–80
   PubMed Web of Science ®Google Scholar
• Witherspoon R. P., Storb R., Ochs H. D., Fluornoy N., Kopecky K. J., Sullivan K. M., Deeg J. H., Sosa R., Noel D. R., Atkinson K., Thomas E. D. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981; 58: 360–8
   PubMed Web of Science ®Google Scholar
• Seddik M., Seemayer T. A., Lapp W. S. The graft-versus-host reaction and immune function. 1. T helper cell immunodeficiency associated with graft-versus-host-induced thymic epithelial cell damage. Transplantation 1984; 37: 281–6
   PubMed Web of Science ®Google Scholar
• Maeda Y., Teshima T., Yamada M., Shinagawa K., Nakao S., Ohno Y., Kojima K., Hara M., Nagafuji K., Hayashi S., Fukuda S., Sawada H., Matsue K., Fakenaka K., Ishimaru F., Ikeda K., Niiya K., Harada M. Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Braematol J H. 1999; 105: 295–302
   PubMed Web of Science ®Google Scholar
• Ottinger H. D., Beelen D. W., Scheulen B., Schaefer U. W., Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow [see comments]. Blood 1996; 88: 2775–9
   PubMed Web of Science ®Google Scholar
• Talmadge J. E., Reed E., Ino K., Kessinger A., Kuszynski C., Heimann D., Varney M., Jackson J., Vose J. M., Bierman P. J. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997; 19: 161–72
   PubMed Web of Science ®Google Scholar
• Miller W., Flynn P., McCullough J., Balfour H. H., Jr., Goldman A., Haake R., McGlave P., Ramsay N., Kersey J. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 1986; 67: 1162–7
   PubMed Web of Science ®Google Scholar
• Sawtell N. M., Poon D. K., Tansky C. S., Thompson R. L. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 1998; 72: 5343–50
   PubMed Web of Science ®Google Scholar
• Wald A., Zeh J., Selke S., Ashley R. L., Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333: 770–5
   PubMed Web of Science ®Google Scholar
• Wald A., Corey L., Cone R., Hobson A., Davis G., Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 1997; 99: 1092–7
   PubMed Web of Science ®Google Scholar
• Wood M. J. Viral infections in neutropenia-current problems and chemotherapeutic control. J Antimicrob Chem-other 1998; 41 Suppl D: 81–93
   PubMed Web of Science ®Google Scholar
• Saral R., Burns W. H., Laskin O. L., Santos G. W., Lietman P. S. Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 1981; 305: 63–7
   PubMed Web of Science ®Google Scholar
• Momin F., Chandrasekar P. H. Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 1995; 123: 205–15
   PubMed Web of Science ®Google Scholar
• Wingard J. R. Viral infections in leukemia and bone marrow transplant patients. Leuk Lymphoma 1993; 11(Suppl 2)115–25
   PubMed Web of Science ®Google Scholar
• Ljungman P. Immune reconstitution and viral infections after stem cell transplantation. Bone Marrow Transplant 1998; 21(Suppl 2)S72–4
   PubMedGoogle Scholar
• Simmons A., Nash A. A. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis 1987; 155: 649–54
   PubMed Web of Science ®Google Scholar
• York I. A., Roop C., Andrews D. W., Riddell S. R., Graham E L., Johnson D. C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 1994; 77: 525–35
   PubMed Web of Science ®Google Scholar
• Cunningham A. L., Turner R. R., Miller A. C., Para M. F., Merigan T. C. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest 1985; 75: 226–33
   PubMed Web of Science ®Google Scholar
• Van Voorhis W. C., Barrett L. K., Koelle D. M., Nasio J. M., Plummer F. A., Lukehart S. A. Primary and secondary syphilis lesions contain mRNA for Thl cytokines. J Infect Dis 1996; 173: 491–5
   PubMed Web of Science ®Google Scholar
• Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749–95
   PubMed Web of Science ®Google Scholar
• Koelle D. M., Tigges M. A., Burke R. L., Symington F. W., Riddell S. R., Abbo H., Corey L. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J Chi Invest 1993; 91: 961–8
   PubMed Web of Science ®Google Scholar
• Posavad C. M., Koelle D. M., Corey L. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nut Med 1998; 4: 381–2
   PubMed Web of Science ®Google Scholar
• Atkinson K., Meyers J. D., Storb R., Prentice R. L., Thomas Dee E. D. Varicella-zoster virus infection after marrow marrow transplantation for aplastic anemia or leukemia. Transplantation 1980; 29: 47–50
   PubMed Web of Science ®Google Scholar
• Steiner I. Human herpes viruses latent infection in the nervous system. Immunol Rev 1990; 152: 157–73
   Web of Science ®Google Scholar
• Koc Y., Miller K. B., Schenkein D. P., Griffith J., Akhtar M., Des Jardin J., Snydman D. R. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency risk factors, and clinical outcome [In Process Citation]. Biol Blood Marrow Transplant 2000; 6: 44–9
   PubMed Web of Science ®Google Scholar
• Wilson A., Sharp M., Koropchak C. M., Ting S. F., Arvin Grov A. M. Subclinical varicella-zoster virus varicella herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens alter bone marrow transplantation. J Infect Dis 1992; 165: 119–26
   PubMed Web of Science ®Google Scholar
• Meyers J. D., Flournoy N., Thomas E. D. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J infect. Dis 1980; 141: 370–87
   PubMedGoogle Scholar
• Arvin A. M., Sharp M., Smith S., Koropchak C. M., Diaz P. S., Kinchington P., Ruyechan W., Hay J. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J Immunol 1991; 146: 257–64
   PubMed Web of Science ®Google Scholar
• Wallace L. E., Rickinson A. B., Rowe M., Epstein M. A. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 1982; 297: 313–5
   Web of Science ®Google Scholar
• Pearson G. R., Orr T. W. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J Natl Cancer Inst 1976; 56: 485–8
   PubMed Web of Science ®Google Scholar
• Blazar B., Patarroyo M., Klein E., Klein G. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate. J Exp Med 1980; 151: 614–27
   PubMed Web of Science ®Google Scholar
• Hasler F., Bluestein H. G., Zvaifler N. J., Epstein L. B. Analysis of thc defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med 1983; 157: 173–88
   PubMed Web of Science ®Google Scholar
• Mathur A., Kamat D. M., Filipovich A. H., Steinbuch And M., Shapiro R. S. Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Transplantation 1994; 57: 1042–5
   PubMed Web of Science ®Google Scholar
• Papadopoulos E. B., Ladanyi M., Emanuel Mackinnon D. S., Boulad E, Carabasi M. H., Castro-Malaspina H., Childs B. H., Gillio A. P., Small T. N., et al. Infusions of. donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation [see comments]. N Engl J Med 1994; 330: 1185–91
   PubMed Web of Science ®Google Scholar
• Shapiro R. S., McClain K., Frizzera G., Gajl-Peczalska K. J., Yark J. H., Blazar B. R., Arthur D. C., Patron D. E., Green-Berg S., Burke B., et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234–43
   PubMed Web of Science ®Google Scholar
• Lucas K. G., Filo K, Heilman D. K., Lee C. H., Emanuel D. J. Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease. Blood 1998; 92: 3977–8
   PubMed Web of Science ®Google Scholar
• Rooney C. M., Loftin S. K., Holladay M S., Brenner M. K., Krance R. A., Heslop H. E. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J. Haematol 1995; 89: 98–103
   PubMed Web of Science ®Google Scholar
• Deeg H. J., Socie G. Malignancies after hematopoietic stem cell transplantation many questions some answers. Blood 1998; 91: 1833–44
   PubMed Web of Science ®Google Scholar
• O'Reilly R. J., Small T. N., Papadopoulos E., Lucas K., Lacerda J., Koulova L. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol 1998; 20: 455–91
   PubMed Web of Science ®Google Scholar
• Heslop H. E., Rooney C. M. Adoptive cellular immunotherapy for EKV lymphoproliferative disease. Immunol Rev. 1997; 157: 217–22
   PubMed Web of Science ®Google Scholar
• Gross T. G., Steinbuch M., De For T., Shapiro R. S., MeGleve P., Ramsay N. K., Wagner J. E., Filipovich A. H. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors. treatment and oucome. Bone Marrow Transplant 1999; 23(25)1–8
   PubMedGoogle Scholar
• Lucas K. G., Small T. N., Heller G., Dupont B., O'Reilly R. J. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 1996; 87: 2591–603
   Google Scholar
• Rooney C. M., Smith C. A., Ng C. Y., Loftin S., Li C., Krance R. A., Brenner M. K., Heslop H. E. Use of gene-modified virus-specific T lymphocytes to control Epstein- Barr-virus-related lymphocytes. Lancet 1995; 345: 9–13
   PubMed Web of Science ®Google Scholar
• Heslop H. E., Ng C. Y., Li C., Smith C. A., Loftin S. K., Krance R. A., Brenner M. K., Rooney C. M. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 1996; 2: 551–5
   PubMed Web of Science ®Google Scholar
• Meyers J. D., Flournoy N., Thomas E. D. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect Dis 1986; 153: 478–88
   PubMed Web of Science ®Google Scholar
• Meyers J. D., Flournoy N., Thomas E. D. Nonbacterial pneumonia after human marrow transplantation. Rev Infect Dis 1982; 4: 1119–32
   PubMedGoogle Scholar
• Reed E. C., Bowden R. A., Dandliker P. S., Lilleby K. E., Meyers J. D. Treatment of cytomegalovirus pneumotia with ganeiclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplant. Ann Intern Med 1988; 109: 783–8
   PubMed Web of Science ®Google Scholar
• Frank I., Friedman H. M. Progress in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1988; 109: 769–71
   PubMed Web of Science ®Google Scholar
• Emanuel D., Cunningham I., Jules-Elysee K., Brochstein J. A., Kernan N. A., Laver J., Stover D., White D. A., Fels A., Polsky B., et al. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganeiclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777–82
   PubMed Web of Science ®Google Scholar
• Schmidt G. M., Kovaes A., Zaia J. A., Horak D. A., Blume K. G., Nademanee A. P., O'Donnell M. R., Snyder D. S., Forman S. J. Ganeiclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipient. Transplantation 1988; 46: 905–7
   PubMed Web of Science ®Google Scholar
• Marks D. I., Cullis J. O., Ward K. N., Lacey S., Syzdlo R., Hughes T. P., Schwarer A. P., Lutz E., Barrett A. J., Hows J. M., et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207–14
   PubMed Web of Science ®Google Scholar
• Takenaka Gondo K. H., Tanimoto K., Nagafuji K., Fujisaki T., Mizuno S., Miyamoto T., Okamura T., Hayashi S., Eto T., Osaki K., Yamasaki K., Shibuya T., Harada N., Teshima T., Matsuishi E., Minematsu T., Minamishima Y., Harada M., Niho Y. Increased incidence of cytomegalovirus (CMV) infection and CMV- associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group [see comments]. Bone Marrow Transplant 1997; 19: 241–8
   PubMed Web of Science ®Google Scholar
• Soderberg-Naucler C., Fish K. N., Nelson J. A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119–26
   PubMed Web of Science ®Google Scholar
• Cheung K. S., Lang D. J. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J infect Dis 1977; 135: 841–5
   PubMed Web of Science ®Google Scholar
• Braun R. W., Reiser H. C. Replication of human cytomegalovirus in human peripheral blood T cells. J Virol 1986; 60: 29–36
   PubMed Web of Science ®Google Scholar
• Klein H. G. Wolf in wolfs clothing: is it time to raise the bounty on the passenger leukocyte? [editorial]. Blood 1992; 80: 1865–8
   PubMed Web of Science ®Google Scholar
• Meyers J. D., Ljungman P., Fisher L. D. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. J infect Dis 1990; 162: 373–80
   PubMed Web of Science ®Google Scholar
• The T. H., van der Ploeg M., van den Berg A. P., Vlieger A. M., van der Giessen M., van Son W. J. Direct detection of cytomegalovirus in peripheral blood leukocytes-a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992; 54: 193–8
   PubMed Web of Science ®Google Scholar
• Boeckh M., Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998; 11: 533–54
   PubMed Web of Science ®Google Scholar
• Griffiths P. D., Grundy J. E. Molecular biology and immunology of cytomegalovirus. Biochem J 1987; 241: 313–24
   PubMed Web of Science ®Google Scholar
• Pass R. F., Stagno S., Britt W. J., Alford C. A. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983; 148: 953–61
   PubMed Web of Science ®Google Scholar
• Quinnan G. V., Jr., Kirmani N., Rook A. H., Manischewitz J. F., Jackson L., Moreschi G., Santos G. W., Saral R., Burns W. H. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T- lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982; 307: 7–13
   PubMed Web of Science ®Google Scholar
• Riddell S. R., Watanabe K. S., Goodrich J. M., Li C. R., Agha M. E., Greenberg P. D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones [see comments]. Science 1992; 257: 238–41
   PubMed Web of Science ®Google Scholar
• Reusser P., Riddell S. R., Meyers J. D., Greenberg P. D. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373–80
   PubMed Web of Science ®Google Scholar
• Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor [see comments]. N Engl J Med 1995; 333: 1038–44
   PubMed Web of Science ®Google Scholar
• Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum [see comments]. Lancet 1988; 1: 1065–7
   PubMed Web of Science ®Google Scholar
• Frenkel N., Katsafanas G. C., Wyatt L. S., Yoshikawa T., Asano Y. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6. Bone Marrow Transplant 1994; 14: 839–43
   PubMed Web of Science ®Google Scholar
• Cone R. W., Hackman R. C., Huang M. L., Bowden R. A., Meyers J. D., Metcalf M., Zeh J., Ashley R., Corey L. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation [see comments]. N Engl J Med 1993; 329: 156–61
   PubMed Web of Science ®Google Scholar
• Asano Y., Yoshikawa T., Suga S., Nakashima T., Yazaki T., Fukuda M., Kojima S., Matsuyama T. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia [letter]. N Engl J Med 1991; 324: 634–5
   PubMed Web of Science ®Google Scholar
• Carrigan D. R., Drobyski W. R., Russler S. K., Tapper M. A., Knox K. K., Ash R. C. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991; 338: 147–9
   PubMed Web of Science ®Google Scholar
• Drobyski W. R., Knox K. K., Majewski D., Carrigan D. R. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356–60
   PubMed Web of Science ®Google Scholar
• Cone R. W., Huang M. L., Corey L., Zeh J., Ashley R., Bowden R. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 1999; 179: 311–8
   PubMed Web of Science ®Google Scholar
• Carrigan D. R., Knox K. K. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6- associated bone marrow suppression in bone marrow transplant patients [see comments]. Blood 1994; 84: 3307–10
   PubMed Web of Science ®Google Scholar
• Drobyski W. R., Dunne W. M., Burd E. M., Knox K. K., Ash R. C., Horowitz M. M., Flomenberg N., Carrigan D. R. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a mar-row-suppressive role for HHV-6 in vivo. J infect Dis 1993; 167: 735–9
   PubMed Web of Science ®Google Scholar
• Corbellino M., Lusso P., Gallo R. C., Parravicini C., Galli M., Moroni M. Disseminated human herpesvirus 6 infection in AIDS [letter] [see comments]. Lancet 1993; 342: 1242
   PubMed Web of Science ®Google Scholar
• Knox K. K., Carrigan D. R. HHV-6 and CMV pneumonitis in immunocompromised patients [letter: comment]. Lancet 1994; 343: 1647
   PubMed Web of Science ®Google Scholar
• Yasukawa M., Yakushijin Y., Furukawa M., Fujita S. Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol 1993; 67: 6259–64
   PubMed Web of Science ®Google Scholar
• Wang F. Z., Dahl H., Linde A., Brytting M., Ehrnst A., Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615–20
   PubMed Web of Science ®Google Scholar
• Isomura H., Yamada M., Yoshida M., Tanaka H., Kitamura T., Oda M., Nii S., Seino Y. Suppressive effects of human herpesvirus 6 on in vitro colony formation of hematopoietic progenitor cells. J Med Virol 1997; 52: 406–12
   PubMed Web of Science ®Google Scholar
• Isomura H., Yoshida M., Namba H., Fujiwara N., Ohuchi R., Uno F., Oda M., Seino Y., Yamada M. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro. J Gen Virol 2000; 81: 663–673
   PubMed Web of Science ®Google Scholar
• Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science 1994; 266: 1865–9
   PubMed Web of Science ®Google Scholar
• Ganem D. KSHV and Kaposi's sarcoma: the end of the beginning. Cell 1997; 91: 157–60
   PubMed Web of Science ®Google Scholar
• Cesarman E., Chang Y., Moore P. S., Said J. W, Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas [see comments. N Engl J Med 1995; 332: 1186–91
   PubMed Web of Science ®Google Scholar
• Regamey N., Tamm M., Wernli M., Witschi A., Thiel G., Cathomas G., Erb P. Transmission of human herpesvirus 8 infection from renal-transplant conors to recipients [see comments]. N Engl J Med 1998; 339: 1358–63
   PubMed Web of Science ®Google Scholar
• Parravicini C., Olsen S. J., Capra M., Poli F., Sirchia G., Gao S. J., Berti E., Nocera A., Rossi E., Bestetti G., Pizzuto M., Gilli M., Moroni M., Moore P. S., Corbellino M. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997; 90: 2826–9
   PubMed Web of Science ®Google Scholar
• Frances C., Mouquet C., Calvez V. Human herpesvirus 8 and renal transplantation [letter comment. N Engl J Med 1999; 340: 1045, discussion 1046
   PubMedGoogle Scholar
• Erer B., Angelucci E., Muretto P., Ripalti M., Rapa S., Gaziev D., Baronciani D. Kaposi's sarcoma after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 629–31
   PubMed Web of Science ®Google Scholar
• Rosenzwajg M., Fery N., Bons V., Damaj G., Gluckman E., Gluckman J. Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipient. Bone Marrow Transplant 1999; 24: 351–4
   PubMed Web of Science ®Google Scholar
• Storek J., Witherspoon R. P., Maloney Chauncey D. G.T.R., Storb R. Improved reconstitution of CL4 T cells and B cells bur worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow [letter comment. Blood 1097; 89: 3891–3
   Google Scholar
• Modigliani Y., Coutinho G., Burlen-Defranoux O., Coutinho A., Bandeira A. Differential contribution of thymic outputs and peripheral expansion in the development of peripheral T cell pools. Eur J Immunol 1094; 24: 1223–7
   Google Scholar
• Tanchot C., Rocha B. Peripheral selection of T cell repertoires: the role of continuous thymus output. J Exp Med 1997; 186: 1090–106
   Web of Science ®Google Scholar
• Berzins S. P., Boyd K. L., Miller J. F. The role of the thymus and recent thymic migrants in the maintenance ot the adult peripheral lymphocyte pool. J Exp Med 1998; 187: 1839–48
   PubMed Web of Science ®Google Scholar
• Mackall C. L., Gress R. E. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997; 157: 61–72
   PubMed Web of Science ®Google Scholar
• Shenoy S., Mohanakumar T., Todd G., Westhoff W., Dunnigan K., Adkins D. K., Brown R. A., DiPersio J. F. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant. 1999; 23: 335–46
   PubMed Web of Science ®Google Scholar
• Atkinson K., Storb R., Prentice R. L., Weiden P L., Witherspoon Sullivan R. P.K., Noel D., Thomas E. D. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 720–31
   PubMed Web of Science ®Google Scholar
• Storek J., Gooley T., Witherspoon R. P., Sullivan K. M., Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am. J Hematol 1997; 54: 131–8
   PubMed Web of Science ®Google Scholar
• Storek J., Gooley T., Siadak M., Bensinger W. I., Maloney D. G., Chauncey T. R., Flowers M, Sullivan K. M., Witherspoon R. P., Rowley S. D., Hanson J. A., Storb R., Appelbaum F. R. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease [see comments]. Blood 1997; 90: 4705–9
   PubMed Web of Science ®Google Scholar